Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
Agilent Technologies Inc. (NYSE: A) will present at two major healthcare conferences: the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on January 6, 2022 at 11 a.m. ET and the J.P.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
SANTA CLARA, Calif.--(BUSINESS WIRE)--
Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual Healthcare Conference. Both conferences will be webcast. Details are included below.
J.P. Morgan 40th Annual Healthcare Conference
Date: Jan. 11, 2022 Time: 4:30 p.m. ET/1:30 p.m. PT Presenting for Agilent:
Mike McMullen, Agilent chief executive officer
Links to join the webcast will be available in the "News & Events -- Events" portion of the Investor Relations section of Agilent’s website.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward advancing the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter and Facebook.